No abstract available
Publication types
-
Comparative Study
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Administration, Oral
-
Adrenergic beta-Antagonists / administration & dosage
-
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
-
Aspirin / administration & dosage
-
Atenolol / administration & dosage
-
Capsules
-
Cardiovascular Agents / administration & dosage*
-
Cardiovascular Agents / economics
-
Cardiovascular Diseases / drug therapy*
-
Diuretics / administration & dosage
-
Double-Blind Method
-
Drug Combinations
-
Drug Costs
-
Humans
-
Hydrochlorothiazide / administration & dosage
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
-
India
-
Platelet Aggregation Inhibitors / administration & dosage
-
Primary Prevention
-
Ramipril / administration & dosage
-
Research Design
-
Secondary Prevention
-
Simvastatin / administration & dosage
-
Treatment Outcome
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Capsules
-
Cardiovascular Agents
-
Diuretics
-
Drug Combinations
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Platelet Aggregation Inhibitors
-
Hydrochlorothiazide
-
Atenolol
-
Simvastatin
-
Ramipril
-
Aspirin
Associated data
-
ClinicalTrials.gov/NCT00443794